|
Company
|
||||||
|---|---|---|---|---|---|---|
|
Olema Pharmaceuticals Inc
OLMA
|
NASDAQ
|
USA
|
Healthcare
|
8.97
$
|
2.16
%
|
342.47M
$
|
|
Prime Medicine, Inc. Common Stock
PRME
|
NASDAQ
|
USA
|
Healthcare
|
4.35
$
|
13.56
%
|
346.31M
$
|
|
Design Therapeutics Inc
DSGN
|
NASDAQ
|
USA
|
Healthcare
|
6.53
$
|
2.6
%
|
349.14M
$
|
|
Kamada
KMDA
|
NASDAQ
|
USA
|
Healthcare
|
6.82
$
|
1.47
%
|
352.11M
$
|
|
OmniAb Inc.
OABI
|
NASDAQ
|
USA
|
Healthcare
|
1.49
$
|
4.03
%
|
362.37M
$
|
|
GH Research PLC
GHRS
|
NASDAQ
|
USA
|
Healthcare
|
12.54
$
|
14.19
%
|
364.2M
$
|
|
LakeShore Biopharma Co., Ltd
LSB
|
NASDAQ
|
USA
|
Healthcare
|
0.7006
$
|
2.78
%
|
369.95M
$
|
|
AnaptysBio
ANAB
|
NASDAQ
|
USA
|
Healthcare
|
36.47
$
|
0.3
%
|
375.78M
$
|
|
Sana Biotechnology Inc
SANA
|
NASDAQ
|
USA
|
Healthcare
|
4.9
$
|
1.02
%
|
376.35M
$
|
|
Eagle Pharmaceuticals
EGRX
|
NASDAQ
|
USA
|
Healthcare
|
0.7
$
|
-
|
381.9M
$
|
|
REGENXBIO
RGNX
|
NASDAQ
|
USA
|
Healthcare
|
12.82
$
|
-0.39
%
|
382.7M
$
|
|
Zevra Therapeutics Inc.
ZVRA
|
NASDAQ
|
USA
|
Healthcare
|
10.18
$
|
0.39
%
|
385.74M
$
|
|
Fusion Antibodies PLC
FAB
|
LSE
|
UK
|
Healthcare
|
13.5
£
|
-
|
391.67M
£
|
|
Tectonic Therapeutic, Inc.
TECX
|
NASDAQ
|
USA
|
Healthcare
|
17.6
$
|
3.69
%
|
391.99M
$
|
|
Akebia Therapeutics
AKBA
|
NASDAQ
|
USA
|
Healthcare
|
2.1
$
|
5.24
%
|
400.8M
$
|
|
Neurogene Inc
NGNE
|
NASDAQ
|
USA
|
Healthcare
|
33.14
$
|
3.38
%
|
401.58M
$
|
|
Aura Biosciences Inc
AURA
|
NASDAQ
|
USA
|
Healthcare
|
6.13
$
|
0.82
%
|
408.13M
$
|
|
Esperion Therapeutics
ESPR
|
NASDAQ
|
USA
|
Healthcare
|
2.84
$
|
4.58
%
|
411.8M
$
|
|
Allogene Therapeutics
ALLO
|
NASDAQ
|
USA
|
Healthcare
|
1.24
$
|
2.48
%
|
414.95M
$
|
|
Trevi Therapeutics
TRVI
|
NASDAQ
|
USA
|
Healthcare
|
11.66
$
|
4.39
%
|
416.29M
$
|